BALVERSA 3 mg/1
Erdafitinib · TABLET, FILM COATED · Janssen Products LP
No Recall History
Plain English
BALVERSA is a tablet, film coated containing erdafitinib at 3 mg/1, taken oral. Manufactured by Janssen Products LP.
Key Facts
- Brand Name
- BALVERSA
- Generic Name
- Erdafitinib
- NDC Code (Product)
59676-030- Manufacturer
- Janssen Products LP
- Strength
- 3 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA212018
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 04/12/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is BALVERSA used for?
BALVERSA contains Erdafitinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is BALVERSA a controlled substance?
BALVERSA is not classified as a controlled substance by the DEA.
What is the generic name for BALVERSA?
The generic name for BALVERSA is Erdafitinib. There are no other listed brand versions of Erdafitinib.
What is the NDC code for BALVERSA 3 mg/1?
The NDC (National Drug Code) for BALVERSA 3 mg/1 is 59676-030, listed by Janssen Products LP.
Other BALVERSA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)